Journal article
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease
Authors
Cornely OA; Robertson MN; Haider S; Grigg A; Geddes M; Aoun M; Heinz WJ; Raad I; Schanz U; Meyer RG
Journal
Journal of Antimicrobial Chemotherapy, Vol. 72, No. 12, pp. 3501–3501
Publisher
Oxford University Press (OUP)
Publication Date
December 1, 2017
DOI
10.1093/jac/dkx382
ISSN
0305-7453